NRG Oncology Network Group Operations Center

NRG 行政核心摘要 NRG 肿瘤学 (NRG) 行政核心提供必要的领导和基础设施，以支持 NCI 国家临床试验网络 (NCTN) 成人组中最大的临床试验组合，该网络的成员包括 220 多个主要会员站点，包括几乎每个主要学术参与站点 (LAPS)，并对 NCTN 的整体管理和成功做出了巨大贡献。 NRG 利用非常成功的多 PI 模型来提供非常有能力的领导和科学监督、充满活力的委员会领导和指导、知识渊博且经验丰富的行政和运营领导以及适当的相关支持。 NRG 是一个仅四年前成立的组织，利用其遗留组织的优势，形成了一个综合的、现代的临床试验组织，针对 NCTN 内的特定人群。值得注意的是，即使在三个遗留集团合并的过程中，NRG 在所有领域仍然保持着高生产力，这证明了 NRG 卓越的领导力和周到的组织结构。除了支持自己的目标外，NRG 也是 NCTN 高度协作的成员。 NRG 与其他团体共同领导了多项试验，支持其他团体的 16 项研究，参与了众多 NCI 指定的指导委员会、工作组和工作组，并领导了新的远程监测标准的制定。 NRG 拥有适当的领导力和基础设施，可以继续支持临床试验和会员目标，并继续作为参与的利益相关者参与 NCTN 的整体管理和成功。

NRG Administrative Core Abstract The NRG Oncology (NRG) Administrative Core provides the leadership and infrastructure necessary to support the largest portfolio of clinical trials among the adult groups in the NCI National Clinical Trail Network (NCTN), a membership encompassing over 220 main member sites – including nearly every Lead Academic Participating Site (LAPS) and a robust contribution to the overall management and success of the NCTN. NRG utilizes a highly successful multiple-PI model to provide remarkably capable leadership and scientific oversight, dynamic committee leadership and mentoring, knowledgeable and experienced administrative and operational leadership, and appropriate associated support. NRG, a group formed only four years ago, has leveraged the strengths of its legacy groups to form an integrated, modern clinical trials organization addressing specific populations within the NCTN. It is notable that NRG remained highly productive in all realms even while navigating the merger of the three legacy groups, a testament to the remarkable leadership of NRG and the thoughtful organizational structure put into place. In addition to supporting its own goals, NRG is a highly collaborative member of the NCTN. NRG co-led a number of trials with other groups, championed sixteen studies from other groups, participated in numerous NCI-appointed steering committees, workgroups, and task forces, and led the development of new remote monitoring standards. NRG has the leadership and infrastructure in place to continue to support the clinical trial and membership goals as well as continue to serve as engaged stakeholders in the overall management and success of the NCTN.